Cargando…
Clinical Potential of DNA Methylation in Gastric Cancer: A Meta-Analysis
BACKGROUND: Accumulating evidence indicates aberrant DNA methylation is involved in gastric tumourigenesis, suggesting it may be a useful clinical biomarker for the disease. The aim of this study was to consolidate and summarize published data on the potential of methylation in gastric cancer (GC) r...
Autores principales: | Sapari, Nur Sabrina, Loh, Marie, Vaithilingam, Aparna, Soong, Richie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3338684/ https://www.ncbi.nlm.nih.gov/pubmed/22558417 http://dx.doi.org/10.1371/journal.pone.0036275 |
Ejemplares similares
-
DNA methylation subgroups and the CpG island methylator phenotype in gastric cancer: a comprehensive profiling approach
por: Loh, Marie, et al.
Publicado: (2014) -
Comprehensive profiling of DNA methylation in colorectal cancer reveals subgroups with distinct clinicopathological and molecular features
por: Ang, Pei Woon, et al.
Publicado: (2010) -
High-Throughput Mutation Profiling Changes before and 3 Weeks after Chemotherapy in Newly Diagnosed Breast Cancer Patients
por: Tan, Sing-Huang, et al.
Publicado: (2015) -
Acquired resistance to combination treatment through loss of synergy with MEK and PI3K inhibitors in colorectal cancer
por: Bhattacharya, Bhaskar, et al.
Publicado: (2016) -
Diagnostic accuracy of DNA methylation in detection of gastric cancer: a meta-analysis
por: Hu, Weiling, et al.
Publicado: (2017)